(HealthDay)—Diacetylspermine is a novel prediagnostic serum biomarker for non-small-cell lung cancer (NSCLC), according to a study published online Aug. 17 in the Journal of Clinical Oncology.
Sep 18, 2015
0
9
A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in ...
Aug 18, 2015
0
7
Early-stage Non-small-cell Lung Cancer (NSCLC) is asymptomatic and difficult to detect since no blood test for NSCLC is currently available. In a new study, Chen-Yu Zhang and Chunni Zhang's group at Nanjing Advanced Institute ...
Aug 14, 2015
0
11
Manchester researchers have tested a new way to genetically profile lung cancer samples, potentially allowing doctors to more easily identify the most appropriate treatment for patients.
May 5, 2015
0
7
(HealthDay)—U.S. Food and Drug Administration approval of Opdivo (nivolumab) has been expanded to include advanced non-small cell lung cancer (NSCLC), the agency said Wednesday in a news release.
Mar 4, 2015
0
2
The U.S. Food and Drug Administration today approved a new drug to treat non-small-cell lung cancer (NSCLC), offering patients new hope in fighting this difficult disease. Lung cancer is expected to lead to over 150,000 deaths ...
Dec 15, 2014
0
0
(HealthDay)—U.S. Food and Drug Administration approval of the anti-cancer drug Cyramza (ramucirumab) has been expanded to include aggressive non-small-cell lung cancer (NSCLC), the agency said Friday.
Dec 14, 2014
0
0
A better survival outcome is associated with low blood levels of squamous cell carcinoma antigen, or absence of tumor invasion either into the space between the lungs and chest wall or into blood vessels of individuals with ...
Oct 24, 2014
0
0
Epidermal growth factor receptor (EGFR) mutations found in the circulating free tumor DNA (ctDNA) from the plasma of advanced non-small cell lung cancer (NSCLC) patients correlates well with the EGFR mutations from patient-matched ...
Aug 22, 2014
0
1
Although the targeted cancer treatment drug crizotinib is very effective in causing rapid regression of a particular form of lung cancer, patients' tumors inevitably become resistant to the drug. Now a new drug called ceritinib ...
Mar 26, 2014
0
0
